3Flack J, Neaton J, Daniels B, et al, Ethnicity and renal disease Lessons from the multiple risk factor intervention trial and the treat ment of mild hypertension study[J]. Am J Kidney Dis, 1993,21:31-40.
4Mann JF, Gerstein HC, Pogue J, et al. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial [J]. Ann Intern Med, 2001, 134(8): 629 - 636.
5Anahetm CA: American heart association scientific sessions, De.st of the AHA ,scientific sessions 2001[J]. Rev Cardiovasc Med, 2002, 3 (1): 22-48.
6Askari AT, Aviles R J, Gurm HS, et al. The double jcopardy of diabetes and renal insufficiency in acute coronary syndromes [abstract 1805] [J]. Circulation, 2001, 104 (suppl17): 371 - 379.
7Hillege HL, Janssen WM, BAK AA, et al. Microalbuminuria is common, also in a non- diabetic, non- hypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity[J]. J Intern Med, 2001,249: 519 - 526.
8Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as-predictor of vascular disease in non - diabetic subjects: Islington diabetes survey [J]. Lancet, 1988, 2:530-533.
9Damsgaard EM, Frland A, Jrgensen OD, et al. Microalbuminuria as predictor of increased mortality in elderly people[J]. BMJ, 1990,300: 297 - 300.
10Borch - Johnsen K, Feldt - Rasmussen B, Strandgaard S, et al. Urinary albumin excretion an independent predictor of ischemic heart disease[J]. Arterioscle Thromb Vasc Biol, 1999, 19:1992 - 1997.
4Shulman N B, Ford CE,Hall WD,et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group [J]. Hypertension, 1989,13 ( Suppl 5 ) : 180-193.
5Levey AS, Coresh J, Dolton K, et al. K/DOQ1 Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Part 7. Stratification of risk for progression of kidney disease and development of cazdiovascular disease [ EB/DL ]. http ://www. kidney. org/professionals/doqi/index.cfm ,2002/2003-01-17.
6Culleton BF,Larson MG,Wilson PW,et al. Cardiovascular disease and mortality in a community-based cohort with mild renal insuffciency [J]. Kidney Int, 1999,56(6) :2214-2219.
7Anahetm CA. American Heart Association Scientific Sessions, Best of the AHA Scientific Sessions 2001 [J]. Rev Cardiovasc Med ,2002,3( 1 ):22-48.
8Askari AT,Aviles RJ ,Gurm HS ,et al. The double jeopardy of diabetes and renal insufficiency in acute coronary syndromes [abstract 1805 ] [ J ]. Circulation,2001,104( 17 suppl) : Ⅱ-379.
9Mann JF, Gerstoin HC, Pogue J, et al. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial[J].Ann Intern Med ,2001,134(8 ) :629-636.
10Flack J,Neaton J,Daniels B,et al. Ethnicity and renal disease: lessons from the multiple risk factor inter vention trial and the treatment of mild hypertension study[J]. Am J Kidney Dis, 1993,21:31-40.
